I-PRO InformaPRO
  • HOME
    • About
  • Bioresearch
    • Databases
    • Clinical Trials
    • Statistics
    • Health Economics
    • Health Policies Monitoring >
      • Health Policies Reports
  • R&D
    • Research and Development
    • Web Portals
    • EuResist Network
    • Technological Integration
  • Training
    • CME and academic education
    • Training Web Platforms
    • Distance Education / Remote Training
    • Scientific Workshops
    • Monitors' training
  • Projects
    • LIFE2020: ABILITA2
    • TROCAR
    • MeuSiX
    • KRG-HIS
    • ARCA
    • AMS >
      • ARCA-AMS publications
    • EuResist Project
    • Abilita
    • RARE
    • IKR
    • SecurePhone
    • Webconference
  • Partners
  • Contacts
  • CAREERS
ABILITA2 || TROCAR || MeuSIX ||​ KRG-DHIS ||  ARCA || AMS || ​ABILITA ||RARE ||​ IKR || EuResist ||  SecurePhone 

TROCAR

Clinical and farmacoeconomic evaluation of dosing methods for CARdiac TROponin for the NSTEMI diagnosis in the setting the clinical practice of First Aid Medicine in the national territory.

​TROCAR is an observational study promoted by the ISS (Italian National Health Institute) involving 12 Emergency Units in Italy; IPRO is the in charge CRO for the monitoring and the management of the project; during the 2018 the project plans to record the data of 6.000 patients admitted in the emergency units with thoracic pain; the data will give a relevant assessment of the diagnosis methods and procedures followed by the Italian Emergency Units.

The project has been completed in 2019

InformaPRO S.r.l.             privacy policy

 via Guido Guinizelli, 98 - 00152 ROME  |  Phone +39 065882352  | amministrazione@informa.pro  |  info@informapro.it  |  P.IVA 08095781004